FAP-1: a protein tyrosine phosphatase that associates with Fas

Science
T SatoJ C Reed

Abstract

Fas is a cell surface receptor that controls a poorly understood signal transduction pathway that leads to cell death by means of apoptosis. A protein tyrosine phosphatase, FAP-1, capable of interacting with the cytosolic domain of Fas, was identified. The carboxyl terminal 15 amino acids of Fas are necessary and sufficient for interaction with FAP-1. FAP-1 expression is highest in tissues and cell lines that are relatively resistant to Fas-mediated cytotoxicity. Gene transfer-mediated elevations in FAP-1 partially abolished Fas-induced apoptosis in a T cell line. These findings are consistent with an inhibitory effect of FAP-1 on Fas signal transduction.

References

Dec 1, 1993·The Journal of Experimental Medicine·M R AldersonD H Lynch
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·N P MøllerA Ullrich
Jun 1, 1993·International Immunology·C KlasP H Krammer
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·T SatoH G Wang

❮ Previous
Next ❯

Citations

Jan 1, 1997·Journal of Cellular Biochemistry·B ZhivotovskyS Orrenius
Aug 5, 2000·International Journal of Cancer. Journal International Du Cancer·Y LiT Sato
Jan 20, 1998·Arthritis and Rheumatism·K NishiokaT Kobata
Jun 17, 1998·Arthritis and Rheumatism·E J PetersonG A Koretzky
Dec 1, 1995·Annals of Neurology·D E Bredesen
May 1, 1997·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·J A Frearson, D R Alexander
Jun 1, 1997·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·C P PontingD J Blake
Jul 13, 2002·Cancer·Hans U SchmelzChristoph Sparwasser
Jan 17, 2002·The Journal of Pathology·Tineke TimmerSteven de Jong
Mar 29, 2002·The Journal of Pathology·Anne-Marie F KersemaekersLeendert H J Looijenga
Feb 1, 1997·Protein Science : a Publication of the Protein Society·C P Ponting
Jul 1, 1998·Clinical Immunology and Immunopathology·P L Arscott, J R Baker
Dec 4, 1998·Springer Seminars in Immunopathology·T HasunumaK Nishioka
Sep 1, 1995·Journal of Clinical Immunology·N Oyaizu, S Pahwa
Aug 24, 2001·Brain Tumor Pathology·M IchinoseK Tabuchi
Sep 2, 1998·Immunologic Research·L L Carter, S L Swain
Jan 1, 1996·Pathology Oncology Research : POR·Dean G Tang, Arthur T Porter
Jan 1, 1996·Immunologic Research·E Schattner, S M Friedman
Aug 16, 2001·International Journal of Hematology·Jane E Parker, Ghulam J Mufti
Mar 24, 2005·Cancer Metastasis Reviews·Theresa L Whiteside
Dec 21, 2000·Current Oncology Reports·T L Whiteside
Dec 1, 1995·Immunology Today·D H LynchM R Alderson
Aug 1, 1996·Immunology Today·J A Frearson, D R Alexander
Jan 24, 2004·Brain Research. Brain Research Reviews·Chulhee Choi, Etty N Benveniste
Dec 31, 2003·Journal of Molecular Biology·Ernesto J FuentesAndrew L Lee
Feb 26, 2004·Experimental Cell Research·Shira Granot-Attas, Ari Elson
Sep 29, 1998·Biochemical Pharmacology·F M Uckun
Nov 24, 1999·Journal of the Neurological Sciences·J OualletH Villarroya
Mar 17, 1999·Transplantation Proceedings·L GenestierJ P Revillard
Feb 2, 2000·Urology·N NonomuraA Okuyama
Dec 1, 1996·Trends in Pharmacological Sciences·G P Anderson
Apr 8, 1998·Trends in Neurosciences·B BecherJ P Antel
Nov 14, 1997·Biochimica Et Biophysica Acta·G Ramponi, M Stefani
Mar 19, 1999·Immunology Today·J O'ConnellF Shanahan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis